Orchestra BioMed
OBIO
OBIO
58 hedge funds and large institutions have $47.6M invested in Orchestra BioMed in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+2
Holders Change %
+3.57%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
21
Increased
14
Reduced
16
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.1M |
| 2 |
Renaissance Technologies
New York
|
+$454K |
| 3 |
DMKJ
David M. Knott Jr
|
+$268K |
| 4 |
RI
RTW Investments
New York
|
+$268K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$229K |
Top Sellers
| 1 |
BlackRock
New York
|
-$3.39M |
| 2 |
State Street
Boston,
Massachusetts
|
-$921K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$786K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$403K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$371K |
